KR880009032A - 이미다조-및 트리아졸로티아디아진, 이의 제조방법, 이를 함유하는 약체 및 이의 용도, 및 이의 중간체 - Google Patents

이미다조-및 트리아졸로티아디아진, 이의 제조방법, 이를 함유하는 약체 및 이의 용도, 및 이의 중간체 Download PDF

Info

Publication number
KR880009032A
KR880009032A KR1019880000827A KR880000827A KR880009032A KR 880009032 A KR880009032 A KR 880009032A KR 1019880000827 A KR1019880000827 A KR 1019880000827A KR 880000827 A KR880000827 A KR 880000827A KR 880009032 A KR880009032 A KR 880009032A
Authority
KR
South Korea
Prior art keywords
formula
compound
acid addition
physiologically acceptable
acceptable acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1019880000827A
Other languages
English (en)
Korean (ko)
Inventor
토르바르트 베르너
게베르트 을리히
쉴레이어바흐 루돌프
알. 바르틀레트 로버트
Original Assignee
하인리히 벡커, 베른하르트 벡크
훽스트 아크티엔게젤샤프트
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 하인리히 벡커, 베른하르트 벡크, 훽스트 아크티엔게젤샤프트 filed Critical 하인리히 벡커, 베른하르트 벡크
Publication of KR880009032A publication Critical patent/KR880009032A/ko
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/84—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/86—Oxygen and sulfur atoms, e.g. thiohydantoin

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
KR1019880000827A 1987-01-30 1988-01-30 이미다조-및 트리아졸로티아디아진, 이의 제조방법, 이를 함유하는 약체 및 이의 용도, 및 이의 중간체 Withdrawn KR880009032A (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19873702757 DE3702757A1 (de) 1987-01-30 1987-01-30 Neue imidazo- und triazolo-thiadiazine, verfahren zu ihrer herstellung, die sie enthaltenden arzneimittel und ihre verwendung, sowie einige bei der herstellung der genannten verbindungen gebildete zwischenprodukte
DEP3702757.3 1987-01-30

Publications (1)

Publication Number Publication Date
KR880009032A true KR880009032A (ko) 1988-09-13

Family

ID=6319855

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019880000827A Withdrawn KR880009032A (ko) 1987-01-30 1988-01-30 이미다조-및 트리아졸로티아디아진, 이의 제조방법, 이를 함유하는 약체 및 이의 용도, 및 이의 중간체

Country Status (18)

Country Link
US (1) US4891374A (https=)
EP (1) EP0280868B1 (https=)
JP (1) JPS63192783A (https=)
KR (1) KR880009032A (https=)
AT (1) ATE77379T1 (https=)
AU (1) AU599200B2 (https=)
DE (2) DE3702757A1 (https=)
DK (1) DK48088A (https=)
ES (1) ES2051778T3 (https=)
FI (1) FI880384A7 (https=)
GR (1) GR3005466T3 (https=)
IE (1) IE880247L (https=)
IL (1) IL85229A (https=)
NO (1) NO880404L (https=)
NZ (1) NZ223334A (https=)
PH (1) PH24526A (https=)
PT (1) PT86655B (https=)
ZA (1) ZA88640B (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0604365B1 (en) * 1992-12-23 1999-05-26 Novartis AG Imidazole derivatives and their use as agrochemical agents
US5510361A (en) * 1994-10-20 1996-04-23 The Procter & Gamble Company Di-tert-butylphenol compounds with heterocyclic moiety, useful as anti-inflammatory agents
JP2001181191A (ja) * 1999-12-24 2001-07-03 Cci Corp 慢性関節リウマチ疾患予防および治療剤
AU2003235741B8 (en) * 2002-01-07 2009-01-15 Eisai R&D Management Co., Ltd. Deazapurines and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL123292C (https=) * 1964-04-09

Also Published As

Publication number Publication date
EP0280868A2 (de) 1988-09-07
AU1099888A (en) 1988-08-04
EP0280868B1 (de) 1992-06-17
NO880404L (no) 1988-08-01
IL85229A0 (en) 1988-07-31
NO880404D0 (no) 1988-01-29
PH24526A (en) 1990-07-18
US4891374A (en) 1990-01-02
FI880384A7 (fi) 1988-07-31
ES2051778T3 (es) 1994-07-01
DE3702757A1 (de) 1988-08-11
NZ223334A (en) 1989-08-29
AU599200B2 (en) 1990-07-12
GR3005466T3 (https=) 1993-05-24
IE880247L (en) 1988-07-30
IL85229A (en) 1991-12-12
FI880384A0 (fi) 1988-01-28
EP0280868A3 (en) 1988-12-07
DE3871985D1 (de) 1992-07-23
PT86655B (pt) 1992-02-28
JPS63192783A (ja) 1988-08-10
ZA88640B (en) 1988-08-03
DK48088A (da) 1988-07-31
DK48088D0 (da) 1988-01-29
ATE77379T1 (de) 1992-07-15
PT86655A (pt) 1988-02-01

Similar Documents

Publication Publication Date Title
HUP9600448A2 (hu) Naftilvegyületek, e vegyületeket tartalmazó gyógyszerkészítmények, eljárás előállításukra, intermedierjeik és alkalmazásuk
DE3679474D1 (de) N6-disubstituierte purinderivate, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel.
DE3567870D1 (en) Xanthine derivatives, processes for their preparation and pharmaceutical compositions containing them
NZ190623A (en) Substituted 2-aminothiazoles and pharmaceutical compositions containing them
KR900006341A (ko) 이형고리 화합물
KR910015562A (ko) 뇌부전 질환치료용 약제, 신규 2-(1-피페라지닐)-4-페닐시클로알카노 피리미딘 유도체, 및 그의 제법
DK196688A (da) Bicykliske forbindelser og fremgangsmaade til fremstilling deraf
SE8700714D0 (sv) Anvendning av substituerade 4-fenyl-4-oxo-2-butensyraderivat for framstellning av lekemedel for behandling av sjukdomar i matsmeltningskanalen och som antiulcerost lekemedel
KR880009003A (ko) 5-(3-알킬-5-3급 부틸-4-히드록시페닐)-2-아미노-6h-1,3,4-티아디아진, 이의 제조방법, 이를 포함하는 약제 및 이의 용도
KR940009184A (ko) 피라졸 축합환 유도체, 이의 제조방법 및 안드로겐 억제제
DE69417573D1 (de) Tricyclische derivate und phamazeutische zusammensetzungen die sie enthalten
KR880009032A (ko) 이미다조-및 트리아졸로티아디아진, 이의 제조방법, 이를 함유하는 약체 및 이의 용도, 및 이의 중간체
KR900018100A (ko) N-(5,6,7,8-테트라히드로피리도(2,3,-d)피리미딘-6-일-알카노일)-글루탐산 유도체 및 그의 제조방법
ES308210A1 (es) Procedimiento para la obtencion de compuestos piridinicos.
ATE38987T1 (de) Neue 2h-1-benzopyran-2-on-derivate, verfahren zu ihrer herstellung und arzneimittel, die diese verbindungen enthalten.
DK0541407T3 (da) Nitrogenholdige, bicykliske derivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende dem
HU903092D0 (en) Process for the preparation of buten-carboxylic acid derivatives and pharmaceutical compositions containing such compounds
KR970704723A (ko) 항염증제로서 유용한 디히드로벤조푸란 및 관련 화합물(dihydrobenzofuran and related compounds useful as anti-inflammatory agents)
ATE4211T1 (de) Triazolochinazolinonderivate und ihre salze mit den saeuren, ihre herstellung, ihre verwendung als arzneimittel und die sie enthaltenden zusammensetzungen.
GB1514077A (en) Treatment of mycoplasmosis
US4224328A (en) Methods with 1-substituted-4-aryl-quinazolin-2(1H)-ones and thiones and pyrido[2,3-d]pyrimidin-2-ones as platelet aggregation inhibitors
KR880013896A (ko) 벤조푸로[3,2-c]퀴놀린 화합물
KR900001701A (ko) 이미다조피라졸 유도체의 진통제 및 항염제로서의 용도
GB1465993A (en) Fish-treating composition
KR950704322A (ko) 스피로푸라논 유도체 및 그의 신경변성 질환 치료 용도(Spirofuranone Derivatives and Their Use in the Treatment of Neurodegenerative Disorders)

Legal Events

Date Code Title Description
PA0109 Patent application

Patent event code: PA01091R01D

Comment text: Patent Application

Patent event date: 19880130

PG1501 Laying open of application
PC1203 Withdrawal of no request for examination
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid